In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2398-2402

  Tran, Chau Minh ^a   Tanaka, Kaori ^a   Yamagishi, Yuka ^b   Goto, Takatsugu ^a   Mikamo, Hiroshige ^b   Watanabe, Kunitomo ^a  

^a GIFU UNIVERSITY   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; DORIPENEM; MEROPENEM; METRONIDAZOLE; PANIPENEM; RAZUPENEM;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; CLOSTRIDIUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; DESULFOVIBRIO; EGGERTHELLA; EUBACTERIUM; FINEGOLDIA MAGNA; FUSOBACTERIUM; GRAM POSITIVE COCCI; IN VITRO STUDY; INHIBITION KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARVIMONAS MICRA; PEPTONIPHILUS ASACCHAROLYTICUS; PEPTOSTREPTOCOCCUS ANAEROBIUS; PORPHYROMONAS; PREVOTELLA; PREVOTELLA INTERMEDIA; PREVOTELLA MELANINOGENICA; PRIORITY JOURNAL;

BACTERIA, ANAEROBIC; CARBAPENEMS; FUSOBACTERIUM; GRAM-NEGATIVE ANAEROBIC BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PORPHYROMONAS; PREVOTELLA;

EID: 79955538004     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01038-10     Document Type: Article

References (10)

1. Clinical and Laboratory Standards Institute. 2007. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard, 7th ed. CLSI document M11-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
2. Eguchi, K., K. Kanazawa, Y. Eriguchi, and Y. Ueda. 2009. Pharmacodynamics of SMP-601 (PTZ601) against vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in neutrophenic murine thigh infection models. Antimicrob. Agents Chemother. 53:3391-3398.
3. Holdeman, L. V., and W. E. C. Moore. 1977. Anaerobic laboratory manual, 4th ed. Virginia Polytechnic Institute and State University, Blacksburg.
4. Jousimies-Somer, H. R., et al. 2002. Wadsworth-KTL anaerobic bacteriology manual, 6th ed. Star Publishing Co., Belmont, CA.
5. Kihara, R., et al. 2008. Potency of SMP-601, a novel carbapenem, in hematogenous murine bronchopneumonia caused by methicillin-resistant and vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 52:2163-2168.
6. Livermore, D. M., S. Mushtaq, and M. Warner. 2009. Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms. J. Antimicrob. Chemother. 64:330-335.
7. Summanen, P., et al. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, CA.
8. Ueda, Y., et al. 2005. In vitro and in vivo antibacterial activities of SM-216601, a new broad-spectrum parenteral carbapenem. Antimicrob. Agents Chemother. 49:4185-4196.
9. Young, C., et al. 2007. Safety and single dose pharmacokinetics of PZ-601: a novel-investigational broad-spectrum carbapenem, abstr. P1673. Abstr. 17th Eur. Congr. Clin. Microbiol. Infect. Dis.-25th Int. Congr. Chemother.
10. Young, C., et al. 2007. Safety and multiple dose pharmacokinetics of intravenous PZ-601 (SMP-601): a novel carbapenem, abstr. A-39. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.